Research programme: serotonin 2A receptor antagonists - Eli LillyAlternative Names: FMPD
Latest Information Update: 21 Apr 2009
At a glance
- Originator Eli Lilly
- Class Benzodiazepines; Small molecules
- Mechanism of Action Serotonin 2A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Psychotic disorders